Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05995769
PHASE2
Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
Sponsor: University of Calgary
View on ClinicalTrials.gov
Summary
The aim of this study is to determine if a single dose of psilocybin administered with motivational enhancement therapy (MET) can reduce heavy drinking in patients with an alcohol use disorder (AUD).
Official title: Mechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical Trial
Key Details
Gender
All
Age Range
22 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
128
Start Date
2024-03-20
Completion Date
2027-10-01
Last Updated
2024-05-07
Healthy Volunteers
No
Conditions
Interventions
DRUG
Psilocybin
Single dosing session followed by 5 MET weekly sessions starting 24hrs after dosing
Locations (1)
University of Calgary
Calgary, Alberta, Canada